Search results
S.S. Vasan. Professor S.S. Vasan, who goes by his surname, is Honorary Professor of Health Sciences at the University of York (UK) and Honorary Professor of Medical and Health Sciences at the ...
Biography. Professor S.S. Vasan (who goes by his surname) is a public health expert and holds an honorary chair in the Department of Health Sciences. He is the Director of the Office of Medical Research and Innovation, Western Australia, and was previously at the CSIRO Australian Centre for Disease Preparedness as COVID-19 Science Leader.
Dr. S S Vasan. Profile is claimed. MBBS, DNB - General Surgery, DNB - Urology/Genito - Urinary Surgery, FICS. Andrologist. 42 Years Experience Overall (27 years as specialist) Medical Registration Verified. 76% (86 patients) Dr. S S Vasan has Completed his undergraduate study in Medicine from the prestigious St John’s Medical College ...
For nearly thirty years from 1940, the Gemini Studios of Madras (Chennai) was the most influential film-producing organization of India and its founder, the brilliant multi-faceted entrepreneur S.S. Vasan lent substance and quality to the rather fragile and unpredictable movie business.
Apr 12, 2023 · April 8 marked the platinum jubilee of the iconic film Chandralekha, which released on this date in 1948. Gemini, the studio that produced it, folded up in the 1970s. S.S. Vasan (of Gemini Studios ...
Gemini Studios. Gemini Studios was an Indian film studio based in Madras, Tamil Nadu. It was launched when S. S. Vasan, a businessman of many ventures (including the ownership of Ananda Vikatan) bought Motion Picture Producers' Combines from Krishnaswamy Subrahmanyam and renamed it. [1] The studio re-opened under the name Gemini.
May 27, 2020 · Professor S.S Vasan is leading our SARS-CoV-2 virus work and led the pre-clinical trials testing two COVID-19 vaccine candidates. Our scientists are hard at work fighting the current COVID-19 pandemic. One of those scientists is Professor S.S Vasan , who leads our SARS-CoV-2 virus work. He and his team analysed the SARS-COV-2 genome to ...
